Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Qualigen Therapeutics Inc
QLGN
Healthcare
Biotechnology
Qualigen Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing treatments for adult and pediatric cancers. The Company’s business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program (Pan-RAS). Its lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription...
inhibitor with strong binding affinity to G4s prevalent in cancer cells (such as pancreatic cancer). Its Pan-RAS program, which is at the preclinical stage, consists of a family of rat sarcoma virus (RAS) oncogene protein-protein interaction inhibitor small molecules inhibits or block mutated RAS genes’ proteins from binding to their effector proteins thereby leaving the proteins from the mutated RAS unable to cause further harm. Its QN-302 is in a Phase 1a clinical trial.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:QLGN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
Next
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 23, 2021 9:47am
QLGN ..... on watch for continuation
There has to be a reason for yesterdays action
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 22, 2021 4:54pm
QLGN...... sold the remaining balance at $2.50
Cha f'ing Ching !!!!!!!
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 22, 2021 4:31pm
QLGN ..... Now trading at $1.75
Who's your "daddy" ? LMFAO
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Nov 22, 2021 3:36pm
RE:QLGN ..... this might be a moot point but.....
Definitely worth a repeat..... Right Mr. Maggot U can fool some of the people some of the time ....but u can't fool me Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 22, 2021 3:22pm
QLGN .....sold into the strength ; )
Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 22, 2021 3:20pm
QLGN ..... 4 million shares traded ..... WTF ?
Gotta like that
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 22, 2021 3:17pm
QLGN ..... Pop pop pop !!!!!
Yeeha !!!!!!!!!!!!!!!!!!!
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 19, 2021 1:05pm
QLGN ....buying pressure noted ; )
albeit small....lokks like the offer was cleaned out
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 19, 2021 11:52am
QLGN ...... relative size offered ; )
I'm a contrarian.....and I dislike Level II More smoke & mirrors Go scare someone else Mr. Maggot !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Nov 18, 2021 4:49pm
RE:QLGN .... LMFAO $1.00 bid now in PM trading
Funny how that works...... The minute I post.... that bid for size disappears. Who f'ing cares.... Level II is a crock of sh8t anyways
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 18, 2021 4:43pm
QLGN .... LMFAO $1.00 bid now in PM trading
for size. Whatever......I'm in it to win it .... Mr. M will not force my hand wherever this goes. You are stuck with me !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 18, 2021 4:34pm
QLGN ..... this might be a moot point but.....
In my past experience....nothing ever goes up before it goes down.....and vice versa ! Keep shakin the tree Mr. M ; )
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 18, 2021 4:00pm
QLGN .... my Mother loves u Mr. Maggot !
Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 18, 2021 3:57pm
LMFAO
Mr. Maggot doing his thang !!!!
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 18, 2021 3:53pm
QLGN ....nothing better than cheap paper !
Cheers !
Prev
1
2
3
4
5
6
7
8
9
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Stage Set for Creation of a Leading Intermediate Gold Producer